News & Scope Handai Hospital No. 75
Alleviating Pain and Distress of Patients and Families – Palliative Care Center Opens –
We practice general dermatology, in particular providing detailed, specialized and advanced medical care for atopic dermatitis, urticaria, collagen diseases, general skin malignancies, mycosis fungoides, cutaneous ulcers, psoriasis, alopecia, drug eruption, vitiligo, bullous bullosa, as well as hereditary skin diseases such as Ito vitiligo, tuberous sclerosis, Recklinghausen's disease, congenital dyskeratosis and epidermolysis bullosa, and phakomatosis.
Outpatient services are provided to patients with atopic dermatitis, and some may be briefly hospitalized to investigate the cause of aggravated eczema and for patient education. In our relationship with affiliated hospitals, This clinical section serves as a regional designated hospital to treat patients with atopic dermatitis in the areas around Osaka.
For collagen diseases, we mainly focus on the diagnosis and treatment of systemic lupus erythematosus, scleroderma, dermatomyositis, and Sjogren's syndrome. Treatments include internal medicine, mainly steroids and immunosuppressants, and immunoglobulin and endoxan infusions are also conducted with hospitalization.
For psoriasis, we conduct screening examinations for the causes of aggravation, psoriatic arthritis, nail psoriasis and other examinations depending on the patient's skin symptoms, and in addition to topical treatment according to the patient's condition, we conduct treatment with ultraviolet rays, immunosuppressants and biological preparations.
Tuberous sclerosis complex is treated in cooperation with other sections on the 'TSC Board'.
For atopic dermatitis, we conduct comprehensive treatment that incorporates aggravation factor searches, and sweating function and skin barrier function evaluations. For food allergies, we conduct detailed searches for the cause, including load tests. For urticaria, in addition to specialized diagnosis of each disease type, we actively examine and treat cholinergic urticaria. For drug eruption, we are involved in creating a database of causative drugs, and in diagnosing and treating various drug eruptions including severe drug eruptions. A special outpatient clinic for vitiligo vulgaris has been established which proactively carries out the most advanced treatment using ultraviolet irradiation equipment called excimer light. Diagnosis and treatment of malignant skin tumors such as malignant melanoma, basal cell carcinoma and squamous cell carcinoma are performed comprehensively, and a special outpatient clinic for lymphoma has been established, where diagnoses of hematological tumors originating from the skin are confirmed diagnosis and treatment strategies are planned.
Although angiofibroma associated with tuberous sclerosis has no established treatment method other than surgery, we have developed a topical form of rapamycin as a safe, effective and simple therapeutic agent, with clinical trials completed and release due soon. We have further improved this topical medication and developed it as a therapeutic drug for Recklinghausen's skin tumor, for which clinical testing is finished and a clinical trial being planned.
In addition, we plan to conduct a doctor-initiated clinical trial with a combination of human Sendai virus vector and anti-PD-1 antibody against advanced malignant melanoma.
All new patients must consult a doctor who provides examinations for first-time patients for their first examination (excluding alopecia clinic which accepts first-time patients).
The patients are referred to our specialist clinic only if necessary.
|First visit||8:30 am to 11:00 am|
|Revisit||8:30 am to 11:30 am|
|Revisit with appointment||8:30 am to 3:00 pm|
※First-time visitors to Osaka University Hospital must have a referral from a physician.
Monday to Friday
Saturdays, Sundays, Holidays New Year’s Holidays: Dec. 29 to Jan. 3